Immunoreactive serum erythropoietin (EPO) was measured in anemic and non-anemic patients with acquired non-severe aplastic anemia (AA; n = 22) and myelodysplastic syndromes (MDS; n = 31) receiving or not androgens to examine the effect of androgen therapy and anemia on EPO levels in these disorders.
Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men
β Scribed by Jed P. Weber; Patrick C. Walsh; Craig A. Peters; Jerry L. Spivak
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 457 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The authors acknowledge the in-depth support of Tsui-Ying Kau, M.P.H., who provided invaluable biostatistical support for our needed access to Detroit area SEER data. They also acknowledge the SEER data itself (contract N01-CN-65054) and appreciate the SEER Program as a vital resource to investigato
## Abstract In these studies the nematode __Caenorhabditis elegans__ was used as a model to investigate ways to reverse the effects of mechanosensory deprivation on behavior and development. Rose et al. (J Neurosci 2005; 25:7159β7168) showed that worms reared in isolation responded significantly le
## BACKGROUND. Androgen receptor blocking agents have become an established form of therapy for men with disseminated prostate carcinoma. The purpose of this study was to evaluate markers of bone turnover and to measure bone mineral densities (BMD) in men with disseminated prostate carcinoma treat